Syneos Health Reports Second Quarter 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Syneos (SYNH) PT Raised to $105 at Jefferies
August 10, 2021 8:29 AM EDTJefferies analyst David Windley raised the price target on Syneos (NASDAQ: SYNH) to $105.00 (from $102.00) while maintaining a Buy rating.
The analyst commented, "Bookings highlighted SYNH's 2Q, particularly Clinical with 1.45x b2b for 2Q and 1.37x TTM. Because SYNH's revenue and... More
Syneos Health, Inc. (SYNH) Tops Q2 EPS by 1c, Offers FY Guidance
August 9, 2021 6:14 AM EDTSyneos Health, Inc. (NASDAQ: SYNH) reported Q2 EPS of $0.97, $0.01 better than the analyst estimate of $0.96. Revenue for the quarter came in at $1.28 billion versus the consensus estimate of $1.27 billion.
GUIDANCE:
Syneos Health, Inc. sees FY2021 EPS of $4.25-$4.43, versus the... More
